Mild to moderate acne
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Adolescents aged 13 to 17, regardless of gender; 2. Patients diagnosed with mild to moderate acne (Pillsbury International Modified Classification System levels I-II); 3. Lesion sites are on the face; 4. Both patients and their families are willing to participate in and cooperate with this clinical trial, and have signed the informed consent form.
Exclusion criteria
Exclusion criteria: 1.History of systematic use of glucocorticoids within one month prior to treatment, or topical use of corticosteroids and antifungal drugs within one week; 2.Merge patients with other facial skin diseases; 3.Merge serious primary diseases such as cardiovascular, hepatic, renal, and hematopoietic systems, as well as severe mental illness patients; 4.Patients who are allergic to research drugs; 5.Patients who are currently participating in clinical trials of other drugs.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Acne grading;Facial skin lesion count;Recurrence rate of facial skin lesions; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sebaceous gland secretion measurement;Non invasive skin assessment;Researcher evaluation;Facial pores and red areas; | — |
Countries
China
Contacts
Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine